Deccan Herald | BioE3 policy must prioritise biopharma and biomanufacturing

Advanced Biology
Written By Shambhavi Naik

The BioE3 policy must prioritise sectors where current geopolitical developments have created opportunities for Indian companies to enter international markets.

By Shambhavi Naik and Saurabh Todi

Read the full article here.

Shambhavi Naik
Previous

The Quint | One Year On, Should India Revisit its Drone Components Ban?
Next

The Hindu | Perils of decentralisation with Chinese characteristics